Jeremie Martinet
Overview
Explore the profile of Jeremie Martinet including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
356
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Boyer O, Bensoussan D, Bonig H, Chabannon C, Clemenceau B, Cuffel A, et al.
Bone Marrow Transplant
. 2025 Jan;
PMID: 39863732
The accessibility of CAR-T cells in centralized production models faces significant challenges, primarily stemming from logistical complexities and prohibitive costs. However, European Regulation EC No. 1394/2007 introduced a pivotal provision...
2.
Eugene-Norbert M, Cuffel A, Riou G, Jean L, Blondel C, Dehayes J, et al.
J Immunol Methods
. 2023 Dec;
525:113603.
PMID: 38147898
CAR-T cells are T cells expressing a chimeric antigen receptor (CAR) rendering them capable of killing tumor cells after recognition of a target antigen. CD19 CAR-T cells have revolutionized the...
3.
Carrette M, Couderc L, Bubenheim M, Vidal A, Youssouf A, Boyer O, et al.
Pediatr Allergy Immunol
. 2023 Aug;
34(8):e14007.
PMID: 37622254
Background: Most children with peanut sensitisation do not have a clinical peanut allergy (PA). Oral food challenge (OFC) is then necessary to diagnose PA and assess the reactive dose of...
4.
Sugita M, Yamazaki T, Alhomoud M, Martinet J, Latouche J, Golden E, et al.
Cell Death Dis
. 2023 May;
14(5):305.
PMID: 37142568
Autologous T cells engineered to express a chimeric antigen receptor (CAR) specific for CD19 are approved for the treatment of various CD19 hematological malignancies. While CAR T cells induce objective...
5.
Bourdenet G, Pileyre B, Drouot L, Martinet J, Becourt C, Carrette M, et al.
Neuropathol Appl Neurobiol
. 2023 Feb;
49(1):e12889.
PMID: 36751013
Aims: Idiopathic inflammatory myopathies (IIM) are autoimmune inflammatory disorders leading to skeletal muscle weakness and disability. The pathophysiology of IIM is poorly understood due to the scarcity of animal disease...
6.
Lukaszewicz R, Mahay G, Boyer O, Martinet J
Allergy
. 2022 Oct;
77(11):3478-3479.
PMID: 36305472
No abstract available.
7.
Alhomoud M, Martinet J, Sugita M, Gomez-Arteaga A, Guzman M
Methods Cell Biol
. 2022 Feb;
167:185-201.
PMID: 35152996
The landscape of CAR-T detection and monitoring techniques in preclinical models is rapidly evolving. In this chapter, we will discuss the most widely used methods. The chapter begins with elaborating...
8.
Lukaszewicz R, Mahay G, Boyer O, Martinet J
Allergy
. 2021 Jul;
77(1):327-330.
PMID: 34252208
No abstract available.
9.
Boyer O, Bridoux V, Giverne C, Bisson A, Koning E, Leroi A, et al.
Ann Surg
. 2017 Apr;
267(3):443-450.
PMID: 28426476
Objective: The aim of this study was to evaluate the efficacy of intrasphincteric injections of autologous myoblasts (AMs) in fecal incontinence (FI) in a controlled study. Summary Of Background Data:...
10.
Corbaux C, Seneschal J, Taieb A, Cornelis F, Martinet J, Milpied B
Eur J Dermatol
. 2016 Dec;
27(2):190-191.
PMID: 27965184
No abstract available.